Ira Longini | Academic Influence

Ira Longini's AcademicInfluence.com Rankings

Ira Longini

Mathematics

#5312

World Rank

#7486

Historical Rank

#1762

USA Rank

Statistics

#416

World Rank

#485

Historical Rank

#132

USA Rank

mathematics Degrees

Download Badge

Mathematics

Ira Longini's Degrees

PhD Biostatistics University of California, Berkeley
Masters Biostatistics University of California, Berkeley
Bachelors Mathematics University of California, Berkeley

Similar Degrees You Can Earn

Best Online Bachelor's in Math 2025

Why Is Ira Longini Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Ira M. Longini is an American biostatistician and infectious disease epidemiologist. Early life and education Longini was born in Cincinnati, Ohio. He received his Ph.D. in Biometry and Biomathematics at the University of Minnesota in 1977. He also received a MS in Statistics/Operations Research in 1973 and a BS, Engineering/Operations Research, from the University of Florida in 1971.

(See a Problem?)

Ira Longini's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak (2020) (2808)
Containing Pandemic Influenza at the Source (2005) (1220)
Mitigation strategies for pandemic influenza in the United States. (2006) (1101)
Containing pandemic influenza with antiviral agents. (2004) (746)
Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!) (2017) (716)
Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial (2015) (685)
Modeling targeted layered containment of an influenza pandemic in the United States (2008) (647)
Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study (2020) (575)
The Transmissibility and Control of Pandemic Influenza A (H1N1) Virus (2009) (575)
A mathematical model for the global spread of influenza (1985) (526)
Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China (2020) (496)
The effect of travel restrictions on the spread of the 2019 novel coronavirus (2019-nCoV) outbreak (2020) (426)
Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study (2020) (365)
Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics (2009) (363)
Role of the primary infection in epidemics of HIV infection in gay cohorts. (1995) (355)
Household Transmission of SARS-CoV-2 (2020) (355)
Containing Bioterrorist Smallpox (2002) (353)
Estimating household and community transmission parameters for influenza. (1982) (344)
Assessing the International Spreading Risk Associated with the 2014 West African Ebola Outbreak (2014) (341)
FluTE, a Publicly Available Stochastic Influenza Epidemic Simulation Model (2010) (340)
Household transmission of SARS-CoV-2: a systematic review and meta-analysis of secondary attack rate (2020) (338)
Critical Factors Influencing the Occurrence of Vibrio cholerae in the Environment of Bangladesh (2005) (336)
Population-wide benefits of routine vaccination of children against influenza. (2005) (312)
Study designs for evaluating different efficacy and effectiveness aspects of vaccines. (1997) (308)
Tecumseh study of illness. XIII. Influenza infection and disease, 1976-1981. (1985) (305)
Design and Analysis of Vaccine Studies (2009) (300)
Statistical analysis of the stages of HIV infection using a Markov model. (1989) (297)
DURATION OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION BEFORE DETECTION OF ANTIBODY (1989) (287)
Direct and indirect effects in vaccine efficacy and effectiveness. (1991) (267)
Genital Herpes Has Played a More Important Role than Any Other Sexually Transmitted Infection in Driving HIV Prevalence in Africa (2008) (254)
Spread of Zika virus in the Americas (2017) (252)
SARS-CoV-2 Variants and Vaccines (2021) (247)
Spatiotemporal spread of the 2014 outbreak of Ebola virus disease in Liberia and the effectiveness of non-pharmaceutical interventions: a computational modelling analysis. (2015) (233)
Probability of female-to-male transmission of HIV-1 in Thailand (1994) (223)
Strategy for distribution of influenza vaccine to high-risk groups and children. (2005) (219)
The ecological effects of individual exposures and nonlinear disease dynamics in populations. (1994) (213)
Hand, Foot, and Mouth Disease in China: Patterns of Spread and Transmissibility (2011) (212)
A 4-year study of the epidemiology of Vibrio cholerae in four rural areas of Bangladesh. (2003) (207)
Considerations in boosting COVID-19 vaccine immune responses (2021) (205)
Finding optimal vaccination strategies for pandemic influenza using genetic algorithms. (2005) (201)
Determinants and predictors of dengue infection in Mexico. (1991) (201)
Controlling Endemic Cholera with Oral Vaccines (2007) (191)
Interpretation and estimation of vaccine efficacy under heterogeneity. (1992) (187)
The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study (2016) (175)
Household and community transmission parameters from final distributions of infections in households. (1982) (171)
Statistical inference for infectious diseases. Risk-specific household and community transmission parameters. (1988) (166)
Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study (2021) (163)
Design and interpretation of vaccine field studies. (1999) (162)
Strategies for Pandemic and Seasonal Influenza Vaccination of Schoolchildren in the United States (2009) (158)
Estimates of the US health impact of influenza. (1993) (158)
Assessing the impact of travel restrictions on international spread of the 2014 West African Ebola epidemic. (2014) (155)
Vaccination strategies for epidemic cholera in Haiti with implications for the developing world (2011) (155)
Antiviral effects on influenza viral transmission and pathogenicity: observations from household-based trials. (2006) (154)
An optimization model for influenza A epidemics (1978) (150)
Neuraminidase Inhibitor Resistance in Influenza: Assessing the Danger of Its Generation and Spread (2007) (149)
Economic evaluation of influenza pandemic mitigation strategies in the United States using a stochastic microsimulation transmission model. (2009) (143)
Inferring high-resolution human mixing patterns for disease modeling (2020) (142)
Markov Chains with Measurement Error: Estimating the ‘True’ Course of a Marker of the Progression of Human Immunodeficiency Virus Disease (1996) (141)
Towards a quantitative understanding of the within-host dynamics of influenza A infections (2010) (140)
Epidemic and endemic cholera trends over a 33-year period in Bangladesh. (2002) (139)
A generalized stochastic model for the analysis of infectious disease final size data. (1991) (135)
El Tor cholera with severe disease: a new threat to Asia and beyond (2009) (135)
School opening dates predict pandemic influenza A(H1N1) outbreaks in the United States. (2010) (132)
Modeling the impact of social distancing, testing, contact tracing and household quarantine on second-wave scenarios of the COVID-19 epidemic (2020) (132)
Predicting the global spread of new infectious agents. (1986) (129)
The dengue vaccine pipeline: Implications for the future of dengue control. (2015) (125)
The dynamics of CD4+ T-lymphocyte decline in HIV-infected individuals: a Markov modeling approach. (1991) (124)
A mathematical model for predicting the geographic spread of new infectious agents (1988) (123)
The ring vaccination trial: a novel cluster randomised controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola (2015) (120)
Environmental and genetic sources of familial aggregation of blood pressure in Tecumseh, Michigan. (1984) (115)
A Frailty Mixture Model for Estimating Vaccine Efficacy (1996) (110)
Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic control. (2000) (110)
Measures of the effects of vaccination in a randomly mixing population. (1991) (110)
No HIV stage is dominant in driving the HIV epidemic in sub-Saharan Africa (2008) (108)
Containing a large bioterrorist smallpox attack: a computer simulation approach. (2007) (105)
The critical vaccination fraction for heterogeneous epidemic models. (2003) (102)
Household Secondary Attack Rate of COVID-19 and Associated Determinants (2020) (100)
Estimability and interpretation of vaccine efficacy using frailty mixing models. (1996) (99)
Subtype-specific transmission probabilities for human immunodeficiency virus type 1 among injecting drug users in Bangkok, Thailand. (2002) (98)
Nonparametric Maximum Likelihood Estimation for Competing Risks Survival Data Subject to Interval Censoring and Truncation (2001) (97)
Controlling Dengue with Vaccines in Thailand (2012) (96)
Assessing risk factors for transmission of infection. (1991) (96)
COVID-19 vaccine trials should seek worthwhile efficacy (2020) (95)
Direct and total effectiveness of the intranasal, live-attenuated, trivalent cold-adapted influenza virus vaccine against the 2000-2001 influenza A(H1N1) and B epidemic in healthy children. (2004) (92)
What is the best control strategy for multiple infectious disease outbreaks? (2007) (91)
Modeling Markers of Disease Progression by a Hidden Markov Process: Application to Characterizing CD4 Cell Decline (2000) (90)
Studies Needed to Address Public Health Challenges of the 2009 H1N1 Influenza Pandemic: Insights from Modeling (2010) (88)
Estimating Influenza Vaccine Efficacy From Challenge and Community-based Study Data (2008) (88)
Factors Associated With Household Transmission of SARS-CoV-2 (2021) (86)
The stages of HIV infection: waiting times and infection transmission probabilities (1989) (86)
The Global Transmission and Control of Influenza (2011) (84)
Estimating efficacy of trivalent, cold-adapted, influenza virus vaccine (CAIV-T) against influenza A (H1N1) and B using surveillance cultures. (2003) (84)
Detecting Human-to-Human Transmission of Avian Influenza A (H5N1) (2007) (83)
Transmission dynamics of Ebola virus disease and intervention effectiveness in Sierra Leone (2016) (81)
Design and evaluation of prophylactic interventions using infectious disease incidence data from close contact groups (2006) (81)
Community interventions and the epidemic prevention potential. (2002) (77)
Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in Guinea, 2016: an operational and vaccine safety report (2017) (73)
Preclinical Assessment of HIV Vaccines and Microbicides by Repeated Low-Dose Virus Challenges (2005) (72)
Community Studies for Vaccinating Schoolchildren Against Influenza (2006) (69)
Quantifying the Epidemiological Impact of Vector Control on Dengue (2016) (69)
Measuring vaccine efficacy for both susceptibility to infection and reduction in infectiousness for prophylactic HIV-1 vaccines. (1996) (69)
Optimal vaccine trial design when estimating vaccine efficacy for susceptibility and infectiousness from multiple populations. (1998) (64)
Transmissibility and Pathogenicity of Ebola Virus: A Systematic Review and Meta-analysis of Household Secondary Attack Rate and Asymptomatic Infection. (2016) (62)
Estimation of vaccine efficacy in the presence of waning: application to cholera vaccines. (1998) (62)
Simulations for designing and interpreting intervention trials in infectious diseases (2017) (61)
The public health value of vaccines beyond efficacy: methods, measures and outcomes (2017) (61)
Optimal Vaccine Allocation for the Early Mitigation of Pandemic Influenza (2013) (59)
Creating a Framework for Conducting Randomized Clinical Trials during Disease Outbreaks. (2020) (59)
Optimizing Vaccine Allocation at Different Points in Time during an Epidemic (2010) (58)
Containing Ebola at the Source with Ring Vaccination (2016) (57)
Placebo-Controlled Trials of Covid-19 Vaccines - Why We Still Need Them. (2020) (54)
Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003-2004. (2007) (54)
Counting Process Models for Infectious Disease Data: Distinguishing Exposure to Infection from Susceptibility (1996) (53)
Exposure efficacy and change in contact rates in evaluating prophylactic HIV vaccines in the field. (1994) (52)
Estimating the stage-specific numbers of HIV infection using a Markov model and back-calculation. (1992) (51)
Household secondary attack rates of SARS-CoV-2 by variant and vaccination status: an updated systematic review and meta-analysis (2022) (51)
Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study (2020) (51)
Antiviral resistance and the control of pandemic influenza: the roles of stochasticity, evolution and model details. (2009) (50)
Spatio-temporal coherence of dengue, chikungunya and Zika outbreaks in Merida, Mexico (2018) (50)
Models for the statistical analysis of infectious disease data. (1988) (49)
Estimating Within-School Contact Networks to Understand Influenza Transmission (2011) (49)
The generalized discrete-time epidemic model with immunity: a synthesis (1986) (49)
A simulation model of AIDS in San Francisco: I. Model formulation and parameter estimation. (1991) (48)
Use of immunological markers and continuous‐time Markov models to estimate progression of HIV infection in homosexual men (1996) (48)
Modelling the female-to-male per-act HIV transmission probability in an emerging epidemic in Asia. (1994) (48)
Live-attenuated tetravalent dengue vaccines: The needs and challenges of post-licensure evaluation of vaccine safety and effectiveness. (2017) (46)
Ebola: mobility data. (2014) (46)
The Cholera Crisis in Africa (2009) (45)
Household Transmission of Vibrio cholerae in Bangladesh (2014) (44)
Effect of routine use of therapy in slowing the clinical course of human immunodeficiency virus (HIV) infection in a population-based cohort. (1993) (44)
Projected Impact of Dengue Vaccination in Yucatán, Mexico (2016) (43)
Efficacy Estimates for Various COVID-19 Vaccines: What we Know from the Literature and Reports (2021) (43)
Household Secondary Attack Rates of SARS-CoV-2 by Variant and Vaccination Status (2022) (42)
Using validation sets for outcomes and exposure to infection in vaccine field studies. (2001) (41)
Measuring vaccine efficacy from epidemics of acute infectious agents. (1993) (40)
The global spread of drug-resistant influenza (2012) (40)
Assessing the Potential of a Candidate Dengue Vaccine with Mathematical Modeling (2012) (39)
Increased Isolation Frequency of Toxigenic Vibrio cholerae O1 from Environmental Monitoring Sites in Haiti (2015) (39)
Molecular Infectious Disease Epidemiology: Survival Analysis and Algorithms Linking Phylogenies to Transmission Trees (2015) (39)
Cryptic transmission of SARS-CoV-2 and the first COVID-19 wave (2021) (38)
Public health. Community studies for vaccinating schoolchildren against influenza. (2006) (38)
Population Level Impact of an Imperfect Prophylactic Vaccine for Herpes Simplex Virus-2 (2010) (37)
Genetic and environmental sources of familial aggregation of body mass in Tecumseh, Michigan. (1984) (37)
Modeling cholera outbreaks. (2014) (36)
Spatiotemporal dynamics of the Ebola epidemic in Guinea and implications for vaccination and disease elimination: a computational modeling analysis (2016) (36)
A discrete-time model for the statistical analysis of infectious disease incidence data. (1992) (36)
Quantifying the importance and location of SARS-CoV-2 transmission events in large metropolitan areas (2020) (35)
Forecasting the effectiveness of indoor residual spraying for reducing dengue burden (2018) (35)
Augmented HIV vaccine trial design for estimating reduction in infectiousness and protective efficacy. (1998) (35)
Quantitative assessment of the role of male circumcision in HIV epidemiology at the population level. (2009) (34)
Estimating the establishment of local transmission and the cryptic phase of the COVID-19 pandemic in the USA (2020) (34)
Design of vaccine efficacy trials during public health emergencies (2019) (34)
Planning for the control of pandemic influenza A (H1N1) in Los Angeles County and the United States. (2011) (34)
Simulation studies of influenza epidemics: assessment of parameter estimation and sensitivity. (1984) (33)
Estimation of vaccine efficacy in outbreaks of acute infectious diseases. (1991) (33)
The Tecumseh study. XII. Enteric agents in the community, 1976-1981. (1983) (32)
Estimation of incidence of HIV infection using cross-sectional marker surveys. (1994) (32)
The Tecumseh Study. XVI: Family and community sources of rotavirus infection. (1989) (32)
Simulation of mechanisms of viral interference in influenza. (1990) (31)
Efficiency of Estimating Vaccine Efficacy for Susceptibility and Infectiousness: Randomization by Individual Versus Household (1999) (30)
Ensemble forecast modeling for the design of COVID-19 vaccine efficacy trials (2020) (30)
Cholera Transmission in Ouest Department of Haiti: Dynamic Modeling and the Future of the Epidemic (2015) (30)
Preliminary assessment of the International Spreading Risk Associated with the 2019 novel Coronavirus (2019-nCoV) outbreak in Wuhan City (2020) (30)
Statistical procedures for estimating the community probability of illness in family studies: rhinovirus and influenza. (1984) (29)
Model‐based estimation of vaccine effects from community vaccine trials (2002) (28)
ESTIMATING WITHIN-HOUSEHOLD CONTACT NETWORKS FROM EGOCENTRIC DATA. (2011) (28)
Have the explosive HIV epidemics in sub-Saharan Africa been driven by higher community viral load? (2013) (27)
School-Located Influenza Vaccination Reduces Community Risk for Influenza and Influenza-Like Illness Emergency Care Visits (2014) (27)
Intervention strategies for an influenza pandemic taking into account secondary bacterial infections. (2009) (27)
A Markov model for measuring vaccine efficacy for both susceptibility to infection and reduction in infectiousness for prophylactic HIV vaccines. (1999) (27)
Estimation of vaccine efficacy from epidemics of acute infectious agents under vaccine-related heterogeneity. (1993) (26)
A Bayesian model for evaluating influenza antiviral efficacy in household studies with asymptomatic infections. (2009) (26)
The Effects of Vector Movement and Distribution in a Mathematical Model of Dengue Transmission (2013) (26)
Comparative Effectiveness of Different Strategies of Oral Cholera Vaccination in Bangladesh: A Modeling Study (2014) (26)
The Effect of Age on Transmission of 2009 Pandemic Influenza A (H1N1) in a Camp and Associated Households (2011) (25)
Critical immune and vaccination thresholds for determining multiple influenza epidemic waves. (2012) (25)
The Tecumseh Community Health Study. (1984) (25)
eAppendix Hand , Foot and Mouth Disease in China : Patterns of Spread and Transmissibility during 2008-2009 (2011) (24)
Dependency of Vaccine Efficacy on Preexposure and Age: A Closer Look at a Tetravalent Dengue Vaccine (2018) (23)
PREDICTIVE MODELING OF CHOLERA OUTBREAKS IN BANGLADESH. (2014) (23)
A chain binomial model of endemicity (1980) (22)
Comparison of Two Smoothing Methods for Exploring Waning Vaccine Effects (1999) (22)
Containing Pandemic Influenza at the Source : Supporting Online Material (2005) (22)
Projected spread of Zika virus in the Americas (2016) (22)
Estimating benefits of screening from observational cohort studies. (1990) (21)
One versus two doses: What is the best use of vaccine in an influenza pandemic? (2015) (21)
Achieving coordinated national immunity and cholera elimination in Haiti through vaccination: a modelling study (2019) (21)
Biofilms Comprise a Component of the Annual Cycle of Vibrio cholerae in the Bay of Bengal Estuary (2018) (20)
A Theoretic Framework to Consider the Effect of Immunizing Schoolchildren Against Influenza: Implications for Research (2012) (20)
Genetic Variation of Vibrio cholerae during Outbreaks, Bangladesh, 2010–2011 (2014) (20)
Modeling Competing Infectious Pathogens From a Bayesian Perspective: Application to Influenza Studies With Incomplete Laboratory Results (2010) (20)
Designing effective control of dengue with combined interventions (2020) (19)
Inferring high-resolution human mixing patterns for disease modeling (2020) (19)
Effects of infection history on dengue virus infection and pathogenicity (2019) (19)
Analytic Insights Into the Population Level Impact of Imperfect Prophylactic HIV Vaccines (2007) (19)
Estimating the effect of cooperative versus uncooperative strategies of COVID-19 vaccine allocation: a modeling study (2020) (19)
The effect of disease prior to an outbreak on estimates of vaccine efficacy following the outbreak. (1995) (18)
Epidemiology of dengue and other arboviruses in a cohort of school children and their families in Yucatan, Mexico: Baseline and first year follow-up (2018) (18)
Semiparametric Methods for Multiple Exposure Mismeasurement and a Bivariate Outcome in HIV Vaccine Trials (1999) (16)
Efficacy of virucidal nasal tissues in interrupting familial transmission of respiratory agents. A field trial in Tecumseh, Michigan. (1988) (16)
Preliminary results of models to predict areas in the Americas with increased likelihood of Zika virus transmission in 2017 (2017) (16)
Emerging, evolving, and established infectious diseases and interventions (2014) (15)
Modeling the decline of CD4+ T-lymphocyte counts in HIV-infected individuals. (1990) (15)
Ebola and beyond (2015) (15)
A Resampling-Based Test to Detect Person-To-Person Transmission of Infectious Disease. (2007) (14)
Binomial and Stochastic Transmission Models (2010) (13)
AIDS: modeling epidemic control (1995) (13)
Have the explosive HIV epidemics in sub-Saharan Africa been driven by higher community viral load? (2013) (13)
Seroprevalence of Dengue Antibodies in Three Urban Settings in Yucatan, Mexico (2018) (13)
COVID-19 vaccine trials: The use of active controls and non-inferiority studies (2021) (13)
Semi-parametric models for mismeasured exposure information in vaccine trials. (1998) (12)
The TIRS trial: protocol for a cluster randomized controlled trial assessing the efficacy of preventive targeted indoor residual spraying to reduce Aedes-borne viral illnesses in Merida, Mexico (2020) (12)
A data-augmentation method for infectious disease incidence data from close contact groups (2007) (11)
Estimation of Vaccine Efficacy in Non‐Randomly Mixing Populations (1995) (11)
Genomic epidemiology supports multiple introductions and cryptic transmission of Zika virus in Colombia (2018) (11)
Transmissibility of Norovirus in Urban Versus Rural Households in a Large Community Outbreak in China (2018) (10)
Models of epidemics and endemicity in genetically variable host populations (1983) (10)
A Bayesian Framework for Estimating Vaccine Efficacy per Infectious Contact. (2009) (9)
Controlling cholera in the Ouest Department of Haiti using oral vaccines (2017) (9)
Chain Binomial Model (2005) (9)
An online decision tree for vaccine efficacy trial design during infectious disease epidemics: The InterVax-Tool (2019) (9)
Quantifying the risk of local Zika virus transmission in the contiguous US during the 2015–2016 ZIKV epidemic (2018) (9)
Cryptic transmission of SARS-CoV-2 and the first COVID-19 wave in Europe and the United States (2021) (8)
Surrogates of Protection (2010) (8)
Determinants of Transmission Risk During the Late Stage of the West African Ebola Epidemic (2019) (8)
Dengue seroprevalence in a cohort of schoolchildren and their siblings in Yucatan, Mexico (2015-2016) (2018) (7)
Real-Time Assessment of the International Spreading Risk Associated with the 2014 West African Ebola Outbreak (2016) (7)
Models for Infectious Human Diseases: Staged Markov models based on CD4+ T-lymphocytes for the natural history of HIV infection (1996) (7)
Intermediate levels of vaccination coverage may minimize seasonal influenza outbreaks (2018) (7)
Comparative modelling of dengue vaccine public health impact: Report to the World Health Organisation (2016) (6)
Questionable efficacy of the rVSV-ZEBOV Ebola vaccine – Authors' reply (2018) (6)
Temporal Confounding in the Test Negative Design. (2020) (6)
Comparative modelling of dengue vaccine public health impact ( CMDVI ) 17 / 03 / 2016 Authors (2016) (6)
DESIGN OF VACCINE TRIALS DURING OUTBREAKS WITH AND WITHOUT A DELAYED VACCINATION COMPARATOR. (2018) (6)
Considerations for the design of vaccine efficacy trials during public health emergencies (2018) (6)
A platform trial design for preventive vaccines against Marburg virus and other emerging infectious disease threats (2022) (5)
Antiviral drugs: distinguish treatment from prophylaxis (2009) (5)
Changes in the primary outcome in Ebola vaccine trial – Authors' reply (2016) (5)
The contribution of neighbours to an individual's risk of typhoid outcome (2015) (5)
Overview of Vaccine Effects and Study Designs (2010) (5)
Appendix Population level impact of an imperfect prophylactic HSV-2 vaccine (2009) (5)
An introduction to the Marburg virus vaccine consortium, MARVAC (2022) (5)
Assessing Indirect, Total, and Overall Effects (2010) (5)
IN4 ECONOMIC EVALUATION OF INFLUENZA PANDEMIC MITIGATION STRATEGIES IN THE US USING A STOCHASTIC MICROSIMULATION INFLUENZA MODEL (2007) (4)
Scheduling Multispecialty Clinics Using Integer Programming (1977) (4)
Extrapolating theoretical efficacy of inactivated influenza A/H5N1 virus vaccine from human immunogenicity studies. (2016) (4)
The ring vaccination trial design for the estimation of vaccine efficacy and effectiveness during infectious disease outbreaks (2022) (4)
Estimating the risk of sustained community transmission of COVID-19 outside Mainland China (2020) (4)
Safety of cold-adapted live influenza vaccine. (2004) (4)
Studies needed to address public health challenges of the 2009 H1N1 influenza pandemic: insights from modeling (2009) (4)
COVID-19 vaccine trials: The potential for “hybrid” analyses (2021) (4)
Modes of Action and Time-Varying VE S (2010) (4)
[Direct and indirect effects of vaccines: an annotation on the estimation of the vaccine efficacy from outbreaks caused by acute infection agents such as measles]. (1990) (3)
Modeling the potential impact of a partially effective HIV vaccine in a generalized African HIV-1 epidemic : Evaluating strategies for HIV vaccine use (2003) (3)
Ebola vaccination – Authors' reply (2015) (3)
Evolutionary consequences of delaying intervention for monkeypox (2022) (3)
Estimation procedures for transmission parameters from influenza epidemics: Use of serological data (1983) (3)
Using simulated infectious disease outbreaks to inform site selection and sample size for individually randomized vaccine trials during an ongoing epidemic (2021) (3)
Guiding Vaccine Efficacy Trial Design During Public Health Emergencies: An interactive web-based decision support tool (2018) (3)
Updated projections for COVID-19 omicron wave in Florida (2022) (3)
The Statistics of HIV. (1994) (2)
Reply to Aguiar and Stollenwerk. (2018) (2)
Designing a Study of Correlates of Risk for Ebola Vaccination (2018) (2)
Algorithms linking phylogenetic and transmission trees for molecular infectious disease epidemiology (2015) (1)
Introduction and Examples (2010) (1)
A mathematical model for the control of dengue using vaccines (2012) (1)
Evaluating Protective Effects of Vaccination (2009) (1)
Estimating the impact of COVID-19 vaccine allocation inequities: a modeling study (2022) (1)
Erratum: Role of the primary infection in epidemics of HIV infection in gay cohorts (Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology (1993) 7 (1169-1184)) (1995) (1)
Effects of infection history on dengue virus infection and pathogenicity (2019) (1)
Household-Based Studies (2009) (1)
Practice of Epidemiology Planning for the Control of Pandemic Influenza A ( H 1 N 1 ) in Los Angeles County and the United States (2011) (1)
Using simulated infectious disease outbreaks to guide the design of individually randomized vaccine trials (2021) (1)
The global transmission and control of influenza : Supporting Text 1 (2011) (1)
Re: "Use of Modeling in Infectious Disease Epidemiology". (1989) (1)
Reply to Vani et al.: Tuberculosis models and complexity (2009) (1)
Understanding HIV epidemics: aggregate viral load metrics and 'smoking guns'. (2013) (0)
Title Quantifying the Epidemiological Impact of Vector Control on Dengue Permalink (2016) (0)
Controlling Ebola with Vaccines : Dynamic Modeling and the Ring Vaccination Trial in Guinea , West Africa Ira Longini (2017) (0)
Projections of Zika spread in the Continental US (2016) (0)
Quantifying the value of viral genomics when inferring who infected whom in the 2014–16 Ebola virus outbreak in Guinea (2023) (0)
COMMENT ON: THE EFFECT OF DISEASE PRIOR TO AN OUTBREAK ON ESTIMATES OF VACCINE EFFICACY FOLLOWING THE OUTBREAK. AUTHORS' REPLY (1996) (0)
Statistical Challenges in Design and Analysis of Ebola Vaccine Trials (2016) (0)
Design of Vaccine Trials during Outbreaks with and without a Delayed Vaccination Comparator (2016) (0)
Immunology and Early Phase Trials (2010) (0)
Vaccine Effects on Post-Infection Outcomes (2010) (0)
A39 Reconstruction of Ebola chains of transmission using sequence and epidemiological data (2019) (0)
Bioterrorism: the statistical issues (2004) (0)
Critical Immune and Vaccination Thresholds in Heterogenous Populations (2010) (0)
Large-scale Individual-based Models of Pandemic Influenza Mitigation Strategies (2007) (0)
Online Supporting Text S 2 : Parameter selection for the model (2012) (0)
Analysis of Households in Communities (2010) (0)
Epidemiology Temporal Confounding in the Test-Negative Design (2020) (0)
Models of the Interaction of Host Genotypes and Infectious Disease (1985) (0)
Supplementary Material: Modeling the impact of social distancing, testing, contact tracing and household quarantine on second-wave scenarios of the COVID-19 epidemic (2020) (0)
he dengue vaccine pipeline : Implications for the future f dengue control (2015) (0)
PIN19: ROUTINE CHILDHOOD VACCINATION AGAINST INFLUENZA:AN ANALYSIS OF CLINICAL AND ECONOMIC BENEFITS (2003) (0)
Modeling progression of HIV infection: staging and the Chicago MACS cohort (1996) (0)
[Procedures for estimating transmission parameters from influenza epidemics: use of serological data]. (1983) (0)
Spatial aspects of influenza epidemics: Andrew D. Cliff, Peter Haggett, and J. Keith Ord, Pion Limited, London, 1986, 280 pp., $52.50 (hardback). (1988) (0)
Online Supporting Text S 1 : Dengue transmission model description (2012) (0)
Randomization and Baseline Transmission (2010) (0)
Further Evaluation of Protective Effects (2010) (0)
Estimation of Vaccine Efficacy for Prophylactic HIV Vaccines (2001) (0)
Models for Infectious Human Diseases: Feasibility of prophylactic HIV-vaccine trials: some statistical issues (1996) (0)
Evaluating targeted COVID-19 vaccination strategies with agent-based modeling (2023) (0)
Fit this SIR model to the data to learn something about the longevity of the immunity to SARS-CoV-2. They also present data on the percentage of seroconverted individuals (2022) (0)
Lecture Notes on Stochastic Processes in Biostatistics: Applications to Infectious Diseases (2003) (0)
Safety of cold-adapted live influenza vaccine. Authors' reply (2004) (0)
Quantifying the risk of local Zika virus transmission in the continental US during the 2015-2016 ZIKV epidemic (2018) (0)
Correction: Cholera Transmission in Ouest Department of Haiti: Dynamic Modeling and the Future of the Epidemic (2016) (0)
R0 and Deterministic Models (2010) (0)
Analysis of Independent Households (2010) (0)
Covariate-constrained randomization with cluster selection and substitution. (2023) (0)

This paper list is powered by the following services:

Other Resources About Ira Longini

en.wikipedia.org

What Schools Are Affiliated With Ira Longini?

Ira Longini is affiliated with the following schools: